Bifidobacterium bifidum – MB109 (DSM 23731)

Discover characteristics, functionalities and scientific support of Bifidobacterium bifidum – MB109 (DSM 23731).

Thearapeutical Area(s): Cardiometabolic

Age/Gender: Adults

Is this strain or blend in your company's portfolio? Contact us.

Cardiovascular health • Cholesterol lowering

Bordoni et al. Cholesterol-lowering probiotics: in vitro selection and in vivo testing of Bifidobacteria. Appl. Microbiol. Biotechnol. 2013. 97:8273-8281.

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

Read MicrobiomePost’s Privacy Policy

This communication is only intended for business-to-business and health care professionals.
This communication is not intended for consumers of final consumer goods.
Nothing on this page is meant to be perceived as an approved claim.

Bifidobacterium bifidum – MB109 (DSM 23731)

Scientific reference(s)